Maastricht University Medical Center+ or Maastricht UMC+ is an academic hospital in the city of Maastricht and affiliated with Maastricht University. Maastricht UMC+ is one of the eight university medical centers in the Netherlands and is part of Netherlands Federation of University Medical Centres

There are 715 beds in Maastricht University Medical Centre; Rheumatology.

During the past decade, Maastricht University Medical Centre; Rheumatology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Maastricht University Medical Centre; Rheumatology" are "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Maastricht University Medical Centre; Rheumatology" in a lesser frequency.

Most popular intervention types in "Maastricht University Medical Centre; Rheumatology" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Methotrexate" (1 trials), "Non-Biologic DMARDs" (1 trials) and "Tocilizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maastricht University Medical Centre; Rheumatology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Maastricht University Medical Centre; Rheumatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Maastricht University Medical Centre; Rheumatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maastricht University Medical Centre; Rheumatology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".